Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • IHH proposes 1.3...

    IHH proposes 1.3 billion dollar bid for Fortis: Report

    Written by Ruby Khatun Khatun Published On 2018-04-12T15:37:49+05:30  |  Updated On 12 April 2018 3:37 PM IST
    IHH proposes 1.3 billion dollar bid for Fortis: Report

    IHH Healthcare Berhad has proposed a potential bid of as much as $1.3 billion for Fortis Healthcare Ltd. that tops an offer from a TPG-backed consortium, according to people with knowledge of the matter, opening a possible takeover battle for India’s second-largest hospital chain.


    Asia’s largest hospital operator sent a letter to the Fortis board Wednesday saying it may be willing to pay as much as 160 rupees per share to acquire control of the Indian company, the people said, asking not to be identified because the information is private. It has asked the Fortis board for some time to update its due diligence before making a formal bid, the people said.



    The Kuala Lumpur-based company’s bid comes just a day after TPG-backed Manipal Health Enterprises Pvt sweetened its offer to hive off Fortis’s hospital operations and merge them with its own business. Manipal said its revised plan gives Fortis shareholders 155 rupees per share in value, up from 140 rupees earlier.


    Fortis shares jumped as much as 4.6 percent, touching a three-week high. IHH shares gained as much as 0.8 percent.

    The potentially competing bids are the latest twist in the Fortis saga, with India’s fraud watchdog and stock regulator investigating the company after Bloomberg News reported the company’s founders took at least 5 billion rupees out of the firm without board approval. Brothers Malvinder Singh and Shivinder Singh have resigned from the company and have lost control of their shareholding due to mounting debt.

    ‘Bidding War’


    Kuala Lumpur-based IHH told the Fortis board it wants to work with them on a friendly offer, according to one of the people.


    “A bidding war is a positive development,” said Nandita Agarwal Parker, managing partner at Karma Capital Management LLC, which holds a minority stake in Fortis. “The board will have to act quickly. Investors need to evaluate the bids in context of all of this and the strategic fit and value add."


    No final decisions have been made, and there’s no certainty IHH will proceed with a bid, the people said. A representative for IHH declined to comment, while a spokesman for Fortis said he couldn’t immediately comment.


    Manipal’s controlling shareholder Ranjan Pai said in an interview Wednesday the reason he was not buying Fortis outright was because of the potential liabilities posed by the investigations. IHH is planning a cash offer for Fortis shares, people with knowledge of the matter said Wednesday. If the approach is rejected by the Fortis board, IHH will consider taking its offer directly to the Indian company’s shareholders, according to the people.


    IHH had engaged in talks early last year to invest in Fortis, people with knowledge of the matter said at the time.


    Article source: Bloomberg
    bidFortisFortis Healthcare LtdIHHIHH HealthcareIHH Healthcare BerhadManipalManipal Health EnterprisesNandita Agarwal Parkerpotential bidproposesRanjan PaitakeoverTPG
    Source : Bloomberg

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok